Thematische Bibliographien / Cerebrovascular disease

Inhaltsverzeichnis

  1. Zeitschriftenartikel
  2. Dissertationen
  3. Bücher
  4. Buchteile
  5. Konferenzberichte
  6. Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Cerebrovascular disease“

Autor: Grafiati
Veröffentlicht am 4. Juni 2021
Zuletzt aktualisiert am 31. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Cerebrovascular disease" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Cerebrovascular disease"

1

Gorelick, Philip B. „Cerebrovascular Disease“. Nursing Clinics of North America 21, Nr. 2 (Juni 1986): 275–88. http://dx.doi.org/10.1016/s0029-6465(22)00416-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Wolf, P. A., und J. C. Grotta. „Cerebrovascular Disease“. Circulation 102, Supplement 4 (14.11.2000): IV—75—IV—80. http://dx.doi.org/10.1161/01.cir.102.suppl_4.iv-75.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Frost, Elizabeth A. M. „Cerebrovascular disease“. Current Opinion in Anaesthesiology 4, Nr. 5 (Oktober 1991): 639–44. http://dx.doi.org/10.1097/00001503-199110000-00002.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Herrick, Ian A. „Cerebrovascular disease“. Current Opinion in Anaesthesiology 16, Nr. 3 (Juni 2003): 337–42. http://dx.doi.org/10.1097/00001503-200306000-00016.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Caprio, Fan Z., und Farzaneh A. Sorond. „Cerebrovascular Disease“. Medical Clinics of North America 103, Nr. 2 (März 2019): 295–308. http://dx.doi.org/10.1016/j.mcna.2018.10.001.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Holloway, R. G. „Cerebrovascular Disease“. Neurology 49, Nr. 4 (01.10.1997): 1192. http://dx.doi.org/10.1212/wnl.49.4.1192.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Sacco, Ralph L., und Tatjana Rundek. „Cerebrovascular disease“. Current Opinion in Neurology 25, Nr. 1 (Februar 2012): 1–4. http://dx.doi.org/10.1097/wco.0b013e32834f89b1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Caplan, Louis R., D. Eric Searls und Fong Kwong Sonny Hon. „Cerebrovascular Disease“. Medical Clinics of North America 93, Nr. 2 (März 2009): 353–69. http://dx.doi.org/10.1016/j.mcna.2008.09.004.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Bowsher, David, G. Vantrappen, David Mabey, Tom Treasure, KentL Woods, WilliamP Arend und David Bowsher. „CEREBROVASCULAR DISEASE“. Lancet 341, Nr. 8838 (Januar 1993): 156. http://dx.doi.org/10.1016/0140-6736(93)90015-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Bonita, Ruth, und Robert Beaglehole. „CEREBROVASCULAR DISEASE“. Lancet 341, Nr. 8859 (Juni 1993): 1510–11. http://dx.doi.org/10.1016/0140-6736(93)90640-3.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Dissertationen zum Thema "Cerebrovascular disease"

1

Holt, Jim, und Gregg Mitchell. „Cerebrovascular Disease KSA“. Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/etsu-works/6458.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Murphy, Jeremy James. „Clinical trials in cerebrovascular disease“. Thesis, University of Nottingham, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293328.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Man, Lai-mei. „An exploratory study for the health seeking pattern of stroke survivors on alternative medicine“. Hong Kong : University of Hong Kong, 1998. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20133236.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Williams, David James. „Near infrared spectroscopy in cerebrovascular disease“. Thesis, University of Bath, 2002. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426180.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Hoffmann, Tammy Coral. „Development and evaluation of a computer-generated individualised written education package for patients following stroke and their carers /“. [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18924.pdf.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Wan, Wai-kuen Christina. „An exploratory design of an empowerment group for the stroke survivors“. Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19469937.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Li, Sijian. „Evaluating the effectiveness of a stroke education programme in Wuhan City of China /“. Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20793224.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Fung, Mei-ling. „Stroke rehabilitation : predicting LOS and discharge placement /“. Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25101298.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Gibbs, Richard Geoffrey James. „The aetiology and epidemiology of cerebrovascular disease“. Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405270.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Chan, Chi-wing Martin. „Is bilateral isokinematic training (BIT) more effective than unilateral limb training in improving the hemiplegic upper-limb function /“. View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30469697.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Bücher zum Thema "Cerebrovascular disease"

1

Hunt, Batjer H., Hrsg. Cerebrovascular disease. Philadelphia: Lippincott-Raven, 1997.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

1924-, Kameyama Masakuni, Tomonaga Masanori und Aiba Tadashi, Hrsg. Cerebrovascular disease. Tokyo: Igaku-Shoin, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Vladimir, Hachinski, Hrsg. Cerebrovascular disease. London: Baillière Tindall, 1995.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

L, Babikian Viken, Wechsler Lawrence R und Higashida Randall T, Hrsg. Imaging cerebrovascular disease. Philadelphia: Butterworth-Heinemann, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

B, Gorelick Philip, und Sloan Michael A, Hrsg. Atlas of cerebrovascular disease. 2. Aufl. Philadelphia: Current Medicine, 2002.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

B, Gorelick Philip, Hrsg. Atlas of cerebrovascular disease. Philadelphia: Current Medicine, 1995.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

S, Moore Wesley, Hrsg. Surgery for cerebrovascular disease. 2. Aufl. Philadelphia: W.B. Saunders, 1996.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

J, Alberts Mark, Hrsg. Genetics of cerebrovascular disease. Armonk, NY: Futura Pub. Co., 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

S, Moore Wesley, Hrsg. Surgery for cerebrovascular disease. New York: Churchill Livingstone, 1987.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

M, Sundt Thoralf, und Meyer Fredric B, Hrsg. Sundt's Occlusive cerebrovascular disease. 2. Aufl. Philadelphia, PA: W.B. Saunders, 1994.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Buchteile zum Thema "Cerebrovascular disease"

1

Wagle, Kamal C. „Cerebrovascular Disease“. In Family Medicine, 837–49. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_72.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Gerhard-Herman, Marie, und Aaron Aday. „Cerebrovascular Disease“. In Manual of Vascular Medicine, 63–72. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44715-1_7.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Roth, Elliot J. „Cerebrovascular Disease“. In Encyclopedia of Clinical Neuropsychology, 740–41. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2167.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Patel, Sheela T., und K. Craig Kent. „Cerebrovascular Disease“. In Surgery, 1005–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-57282-1_45.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Roth, Elliot J. „Cerebrovascular Disease“. In Encyclopedia of Clinical Neuropsychology, 536. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2167.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

McCabe, Melvina. „Cerebrovascular Disease“. In Family Medicine, 557–64. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_65.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Orsini, Donna L., Wilfred G. van Gorp und Kyle B. Boone. „Cerebrovascular Disease“. In The Neuropsychology Casebook, 40–68. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3836-2_2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Fowler, T. J., und R. W. May. „Cerebrovascular Disease“. In Neurology, 115–24. Dordrecht: Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-010-9544-0_8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Roth, Elliot J. „Cerebrovascular Disease“. In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2167-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

McCabe, Melvina L. „Cerebrovascular Disease“. In Family Medicine, 494–501. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-4005-9_65.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Cerebrovascular disease"

1

Axelerad, Docu Any, Daniel Docu-Axelerad und Valentin Negrea. „Smoking and the Cerebrovascular Disease“. In DIALOGO-CONF 2018 OVERPOPULATION AND RELIGION's INVOLMENT (ORI). EDIS - Publishing Institution of the University of Zilina, Slovak Republic, 2018. http://dx.doi.org/10.18638/dialogo.2018.4.2.9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Estévez, M., A. Argibay, L. Rodriguez, M. Freire, B. Gimena, J. Fernández-Martín und A. Rivera. „FRI0289 Cerebrovascular disease in the antiphospholipid syndrome“. In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4509.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Martins, Karine Felipe, Flávia Pascoal Teles, Amanda Fernandes de Sousa Oliveira Balestra und Isadora Rosa Maia. „Cerebrovascular diseases: the importance of recognizing them“. In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.188.

Der volle Inhalt der Quelle
Annotation:
Background: Until the 70s, cerebrovascular diseases (CVDs) were neglected to the lack of resources. However, due to the advancement of technology, several imaging tests have appeared, such as magnetic resonance and computed tomography, which facilitated the diagnosis and the understanding of the pathophysiology of each disease. Objectives: The objective of this work is to identify the main CVDs signs and symptoms. Methods: An integrative literature review was carried out based on selected articles from Google Scholar, PubMed and SciELO, using the terms headache, cerebrovascular disease, neurology. Results: CVDs are characterized by causing damage to brain vessels, due to changes in blood flow momentarily or permanently in an area of the brain, allowing them to be classified as ischemic or hemorrhagic. In ischemic there is a blockage of blood flow and, consequently, of oxygen to areas of the brain, in hemorrhagic rupture of a vessel occurs and, with this, blood leakage. Therefore, it is necessary to recognize the signs and symptoms early, in order to prevent loss of neurological function, movements on one side of the body and the presence or absence of headaches in both patients, with ischemic CVD and hemorrhagic CVD prevent rapid loss of consciousness accompanied by severe headache. Such signs and symptoms associated with the patient’s family history and lifestyle can help in the diagnosis of this disease. Conclusion: Therefore, it is important to recognize the signs and symptoms of CVDs, in order to determine the treatment and advise the patient, which will guarantee a better prognosis.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Gramasco, Hendrick Henrique Fernandes, Mateus Felipe dos Santos, Yasmim Nadime José Frigo, Guilherme Drumond Jardini Anastácio, Stella de Angelis Trivellato, Daniel Fabiano Barbosa dos Santos, Ana Cláudia Pires Carvalho et al. „Diverse clinical presentations of Moyamoya disease: a case series“. In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.530.

Der volle Inhalt der Quelle
Annotation:
Context: Moyamoya disease or chronic occlusive cerebrovascular disease is characterized by proximal occlusion of the internal carotid artery and its branches bilaterally, generating an angiographic “smoke” pattern (moyamoya, from Japanese “something hazy”) and by diverse ischemic manifestations. Case report: The sample consists of three female patients, aged between 13 and 46 years, followed in our service due to the diagnosis of Moyamoya Disease. Among the clinical manifestations presented, ischemic cerebrovascular events with neurological deficit predominated, and one of the patients presented two episodes compatible with stroke and one episode compatible with transient ischemic accident. The youngest patient presented with a choreic picture initially interpreted as Sydenham’s chorea. Although the gold standard for the diagnosis of chronic occlusive cerebrovascular disease is cerebral arterial angiography, it was possible to observe a pattern compatible with the disease in other modalities of examination, such as cerebral arterial angiotomography and cerebral arterial angioresonance. From the therapeutic point of view, one of the patients underwent surgical intervention (encephaloduromyosinangiosis), with improvement of symptoms after treatment. Conclusions: In this paper, we emphasize the importance of complementary imaging tests in the evaluation of patients with cerebrovascular syndromes and the diversity of clinical presentation of Moyamoya disease.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Qiang Sun, Qiang, Jiang Jiang Yuan und Lei Lei Zeng. „Interventional Therapy of Cerebrovascular Disease Mechanical Embolic Materials“. In 2015 International Conference on Mechanical Science and Engineering. Paris, France: Atlantis Press, 2016. http://dx.doi.org/10.2991/mse-15.2016.8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Taylor, Hannah. „BS36 The role of BACE1 in cerebrovascular disease“. In British Cardiovascular Society Annual Conference, ‘Future-proofing Cardiology for the next 10 years’, 5–7 June 2023. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-bcs.249.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Oliveira, Francisco Gabriel Cabral, Juliana Paiva Ribeiro Moura, Matheus Henrique Oliveira und Mylena Teles de Jesus. „The relation between COVID-19 and cerebrovascular diseases“. In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.740.

Der volle Inhalt der Quelle
Annotation:
Introduction: Covid-19 is characterized by respiratory syndrome and has symptoms that affect the central nervous system such as headache, anosmia, hypercoagulability, etc. In this sense, it is known that the virus shows tropism by the receptors of the angiotensin-converting enzyme 2 (ACE2), becoming a gateway to the neurological system, which can cause complications. Is to relate the infection by COVID-19 and the increase in cerebrovascular diseases. Methods: A literature review was carried out using search for scientific articles in PubMed, in April / 2021, with a filter in the last 5 years, using the descriptors “Covid”, “Cerebrovascular Diseases” and “Man” associated with the Boolean operator AND. Results: 53 articles were found, of which 19 were selected for research. There is a higher frequency of neurological symptoms in patients with COVID-19 than in patients without the disease. The effect of binding the virus to ACE2 receptors is to activate a cascade of cytokines, which tends to lead to serious complications. For this reason, severe coagulopathies can be caused, increasing products of the degradation of C-reactive protein, D Dimer, fibrinogen and thrombocytopenia. The increase in cerebrovascular events also occurs because the antithrombotic, neuroprotective, antihypertensive effects, among others, of the alternative renin-angiotensin system in the brain are interrupted due to COVID-19. Conclusion: It was seen that cerebrovascular events are related to the course of COVID-19, in which patients may develop several serious complications, such as encephalitis, strokes and vascular thrombosis. Thus, the pathophysiology of this disease is related to an inflammatory process.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

SOSSI, VESNA. „PET for cerebrovascular diseases: status and limitation“. In Frontiers in Imaging Science: High Performance Nuclear Medicine Imagers for Vascular Disease Imaging (Brain and Heart). Trieste, Italy: Sissa Medialab, 2008. http://dx.doi.org/10.22323/1.039.0017.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Rahman, G. M. Mahmudur, H. Okazawa, Md Sherajul Islam, Md Shahjahan und S. S. Zakir. „Probing the neuronal status for cerebrovascular disease using EEG“. In 2017 International Conference on Electrical, Computer and Communication Engineering (ECCE). IEEE, 2017. http://dx.doi.org/10.1109/ecace.2017.7912926.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Mesquita, Rodrigo da Rosa, Tatiana Farias de Oliveira, Gibson Barros de Almeida Santana, Antônio Leopoldo do Nascimento Gama Albuquerque, Amanda Karine Barros Ferreira Rodrigues und Carlos Dornels Freire de Souza. „Epidemiological profile and temporal trend of mortality from cerebrovascular diseases in Northeast of Brazil, 1996-2016“. In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.600.

Der volle Inhalt der Quelle
Annotation:
Background: Cerebrovascular diseases represent the second leading cause of mortality in the world and Brazil occupies the leadership in the ranking of mortality in South America. Objectives: This study sought to analyze the sociodemographic profile and the time trend of the mortality rate from cerebrovascular disease in the Northeast of Brazil, 1996-2016. Methods: This is an ecological study of time series involving deaths from cerebrovascular diseases in the Northeastern of Brazil, 1996-2016. Sociodemographic variables (age, schooling, marital status, skin color, ICD category and federation units) were included and calculated crude and standardized mortality rates, according to gender and age group. A joinpoint regression model was applied for the temporal analysis, with a level of significance of 5%. Results: There were 490.433 deaths from cerebrovascular diseases in the Northeast of Brazil, 1996-2016. Of these deaths, 50,03% (n = 245.354) were women, 79,72% (n = 390.957) elderly, 46,66% (n = 228.851) brown, 51,81% (n = 332.439) illiterate and 37,93% (n = 186.014) were married. Of the causes of death, 56,63% (n = 277.741) resulted from stroke, not specified as hemorrhagic or ischemic (I64). In the Northeast, there was a predominance of the elderly population, with growth of 1.2% (p < 0.001). Conclusions: Standardized mortality increased in four states, being higher in Maranhão and Piauí, with a predominance of females and age equal to or above 60 years.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Cerebrovascular disease"

1

Chen, Qian, und Qinhao Wang. The neuroprotective effect of edaravone dexborneol in cerebrovascular disease: a comprehensive systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0069.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Roldán-González, Elizabeth, Carolina Robledo-Castro, Piedad Rocío Lerma-Castaño und María Luisa Hurtado-Otero. Validity and reliability of the Wolf Motor Function Test -WMFT in patients with Cerebrovascular disease: Scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Oktober 2022. http://dx.doi.org/10.37766/inplasy2022.10.0044.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: This scoping review aimed to compile the studies that have examined the validity and reliability of the different versions of the Wolf Motor Function Test - WMFT in patients with Cerebrovascular disease. Background: Numerous investigations in rehabilitation have used the WMFT as an instrument for the primary measurement of the results; however, to date, there are no known reviews that have compiled the reliability and validity of the wolf test in its different versions, which is considered of vital importance and constitutes critical information for decision making in the process of evaluation and follow-up of patients with stroke in clinical, academic and research environments.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Hu, XinYi, JingXuan Hao und HangYue Wang. Improvement of Environmental enrichment on Cognitive Functions in Patients and animals : A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Dezember 2022. http://dx.doi.org/10.37766/inplasy2022.12.0014.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: To study the relationship between environmental enrichment and cognitive function through a meta-analysis of the literature, analyze its effects on the improvement of cognitive function in patients and animals, and evaluate the effects of different environmental enrichment measures on cognitive function improvement. Condition being studied: Cognitive decline refers to an individual's memory, language, reasoning and other aspects of cognitive function showing obvious, measurable decline or abnormal. The causes of cognitive decline are various, including neurodegeneration, cerebrovascular disease, infection, trauma, and depression. Alzheimer's disease and stroke are the most common.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Zhang, Ruizhe, und Qingya Xie. A meta-analysis of cholesteryl ester transfer protein(CETP) gene rs708272(G>A) polymorphism in association with cornoary heart disease risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juni 2023. http://dx.doi.org/10.37766/inplasy2023.6.0021.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: To seek the association of the CETP rs708272 polymorphism with CHD.To figure out if the carriers of allele rs708272-A reduce or increase the risk of CHD in comparison with carriers of allele rs708272-G under allele model, dominant model and recessive model. Condition being studied: The inclusion criteria of CHD:(1)the presence of stenosis≥50% in a minimum of one main segment of coronary arteries (the right coronary artery, left circumfex, or left anterior descending arteries) by coronary angiography.(2) symptoms representing angina pectoris, electrocardiographic changes, and elevations of cardiac enzymes based on the criteria of the World Health Organization. (3) a certifed record of coronary artery bypass graft or percutaneous coronary intervention were included in the study.The exclusion criteria of CHD :patients with congenital heart disease, cardiomyopathy, and valvular disease.Controls:the same populations as the cases and specifed to be without CAD, cardiovascular and cerebrovascular diseases, and peripheral atherosclerotic arterial disease.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Roldán-González, Elizabeth, Fernando José Gómez-Rodríguez, Sandra Jimena Jácome-Velasco, Anggie Valentina Sarria Gómez und Luis Alejandro Rosas-Roldán. Systematic Review Protocol: Validity and reliability of the Tardieu scale for assessing upper limb spasticity in adults with cerebrovascular disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2023. http://dx.doi.org/10.37766/inplasy2023.11.0076.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

LI, Peng, und Junjun Liu. Effect of statin therapy on moderate-to-severe depression: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, März 2022. http://dx.doi.org/10.37766/inplasy2022.3.0016.

Der volle Inhalt der Quelle
Annotation:
Review question / Objective: We aim to assess the antidepressant effects of statin therapy among patients complicated with moderate to severe depression. Condition being studied: Depression is one of the major causes of disability worldwide, and major depressive disorders (MDD) contribute to a significant heavy disease burden, which is expected to be second by 2050, only to heart disease. Despite great improvement in therapy, the treatment efficacy remains low. Therefore, alternative therapies have been intensely investigated. A substantial body of researches have suggested that inflammation is one of the operative pathways between MDD and increased risk of somatic comorbidities, and some specific depressive symptoms. Depression occurs in most patients with cardiac and cerebrovascular disease due to the long-term effects, and depression increases the risk of cardiovascular disease in the population as a whole and in patients with coronary artery disease or stroke. Several observational studies have demonstrated reduced rates of depression among patients taking statins, which may be related to its anti-inflammatory effect. However, whether statin improves the depressive symptoms and its associated mechanism is still mixed. Furthermore, there is little evidence about statin treatment effect in those with moderate to severe depression. In addition, whether the effect of statin treatment on depressive symptom changes with time or is affected by baseline depression severity or percentage change of lipid levels has not been explored in previous studies.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Chen, Sijia, Shuangyu Wang und lishuo Gao. Whether nurse-led telephone follow-up is more effective than usual care in improving blood pressure and LDL cholesterol levels in patients with cardiovascular and cerebrovascular disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, März 2024. http://dx.doi.org/10.37766/inplasy2024.3.0054.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Li, Tian, Shanshan Jin, Wenhua Jiang, Nan Mu, Yishi Wang, Xiaokang Li, Yue Yin et al. Metformin may reduce the mortality and cardiac events in patients with cardio-cerebrovascular diseases, irrespective of concurrent diabetes: a meta-analysis of randomized controlled trails and cohort studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juni 2020. http://dx.doi.org/10.37766/inplasy2020.6.0008.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Cerebrovascular disease" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen Bücher
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie